Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3306857 | 0.92 | CDK1 (0.61) | CDK1GAAMEN1KMT2ACYP1A2 | |
| SCHEMBL10396053 | 0.88 | CDK1 (0.62) | CDK1GAAMEN1KMT2ACYP1A2 | |
| SCHEMBL8782215 | 0.88 | CDK1 (0.62) | CDK1GAAMEN1KMT2ACYP1A2 | |
| SCHEMBL5846414 | 0.88 | CDK1 (0.62) | CDK1GAAMEN1KMT2ACYP1A2 | |
| SCHEMBL5847785 | 0.88 | CDK1 (0.61) | CDK1GAACYP1A2MAPTHPGD | |
| SCHEMBL5847781 | 0.88 | CDK1 (0.61) | CDK1GAAMEN1KMT2ACYP1A2 | |
| SCHEMBL8536414 | 0.87 | CDK1 (0.80) | CDK1GAAMEN1KMT2ACYP1A2 | |
| SCHEMBL11385667 | 0.85 | CDK1 (0.57) | CDK1GAACYP1A2MAPTTP53 | |
| SCHEMBL8507050 | 0.84 | CDK1 (0.56) | CDK1GAAMEN1KMT2ACYP1A2 | |
| SCHEMBL10395502 | 0.84 | CDK1 (0.56) | CDK1GAAMEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116600643-A | Herbicide mixture, herbicide composition, method for controlling undesired vegetation and kit | 安道麦阿甘有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-111807997-B | Synthesis method of N- (4-methoxycarbonyl-3-aminosulfonylbenzyl) methanesulfonamide | 南京合创药业有限公司 | 2022-09-23 | — | — | CN | disclosed |
| CN-113999178-A | Method for preparing mesosulfuron-methyl by one-pot method | 江苏省农用激素工程技术研究中心有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113999179-A | Method for synthesizing mesosulfuron-methyl by one-pot method | 江苏省农用激素工程技术研究中心有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-111807997-A | Synthesis method of N- (4-methoxycarbonyl-3-aminosulfonylbenzyl) methanesulfonamide | 南京合创药业有限公司 | 2020-10-23 | — | — | CN | disclosed |
| US-20040171489-A1 | Synergistic active compound combinations for controlling harmful plants | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2004-09-02 | — | — | US | disclosed |
| US-6723681-B2 | HERBICIDE COMBINATIONS WITH AN EFFECTIVE CONTENT OF BROAD-SPECTRUM HERBICIDES FROM THE GROUP GLUFOSINATE (SALTS) AND RELATED COMPOUNDS, GLYPHOSATE (SALTS) AND RELATED COMPOUNDS, IMIDAZOLINONES, HERBICIDAL AZOLES | HOECHST SCHERING AGREVO GMBH (DE) | 2004-04-20 | — | — | US | disclosed |
| US-20030022792-A1 | HERBICIDAL COMPOSITIONS FOR TOLERANT OR RESISTANT CEREAL CROPS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2003-01-30 | — | — | US | disclosed |
| US-20030004064-A1 | Synergistic active compound combinations for controlling harmful plants | AVENTIS CROPSCIENCE GMBH (DE) | 2003-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030004064-A1 | Synergistic active compound combinations for controlling harmful plants | DDT, AADAT, MTX1 | CDK1 487/4885GAA 1094/4885MEN1 3955/4885 |
| US-20030022792-A1 | HERBICIDAL COMPOSITIONS FOR TOLERANT OR RESISTANT CEREAL CROPS | PPOX, PNPO, PAOX | CDK1 1233/4885GAA 1035/4885MEN1 3494/4885 |
| US-20040171489-A1 | Synergistic active compound combinations for controlling harmful plants | L3MBTL4, TTL, EBPL | CDK1 2025/4885GAA 4417/4885MEN1 4434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.